Recruiting Watch-and-Wait Approach With Dostarlimab in Localized dMMR/MSI-H Gastric Cancer: GERCOR Phase II Study NCT06059495 Conditions Adenocarcinoma - GEJ, Gastric Adenocarcinoma Locations CHRU Lille — Lille, France Hôpital Saint Antoine — Paris, France View Trial Details
Not Yet Recruiting A Study of Barrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurrence and the Effect of Risk Profile Disclosure on Patient Quality of Life and Fear of Cancer NCT07455422 Conditions Adenocarcinoma, Adenocarcinoma - GEJ, Barrett Esophagus, +11 more Locations Antwerp University Hospital — Edegem, Antwerpen, Belgium Sint-Augustinus Hospital (ZAS) — Wilrijk, Antwerpen, Belgium Ghent University Hospital (UZ Gent) — Ghent, Belgium AZ Delta — Roeselare, Belgium View more locations Show fewer locations Loading locations... View Trial Details
Completed Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer NCT04984733 Conditions Adenocarcinoma - GEJ, Cancer of Esophagus, Digestive System Diseases, +8 more Locations Cambridge University Hospitals NHS Foundation Trust — Cambridge, Cambridgeshire, United Kingdom View Trial Details
Completed DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02) NCT04014075 Conditions Adenocarcinoma - GEJ, Adenocarcinoma Gastric Stage IV With Metastases, Neoplasm Metastasis, +4 more Locations City of Hope Medical Center — Duarte, California, United States USC Norris Comprehensive Cancer Center Hospital — Los Angeles, California, United States Pacific Cancer Care — Monterey, California, United States UCLA Health — Santa Monica, California, United States View all 37 locations View more locations Show fewer locations Loading locations... View Trial Details
